Help
Subscribe


GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy

 18 January 2018

Advanced search
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy Profile of Roy Pounder

Home

News  
Journals
Review Articles
Slide Atlas
Video Clips
Online Books
Advanced Digestive Endoscopy
Classical Cases
Conference Diary
PubMed
International GH Links
USA GH Links
National GH Links
National GI Societies
Other Useful Links




Emails on Gastroenterology and Hepatology
the National AIDS Treatment Advocacy Project
Visit the gastroenterology section of the EUMS

News

Patients with IBD not receiving optimal care

A study in the latest American Journal of Gastroenterology shows that patients with IBD often do not receive optimal medical therapy that includes failure to use steroid-sparing agents, and inadequate screening for colorectal cancer.

News image

fiogf49gjkf04

Guidelines have been published as a framework for therapy of patients with inflammatory bowel disease (IBD).

Dr Sarathchandra and colleagues from Massachusetts determined whether patients referred for a second opinion were receiving therapy in accordance with practice guidelines.

9 of 12 patients with distal ulcerative colitis were not receiving rectal aminosalicylate therapy
American Journal of Gastroenterology

The researchers enrolled 67 patients with luminal IBD.

The team reported that patients were under the care of a gastroenterologist who sought a second opinion at Brigham and Women's Hospital between 2001 and 2003.

The researchers obtained clinical information by direct patient interview at the time of initial patient visit and by a review of prior records.

The team's data included the diagnosis, clinical symptoms, prior medical therapy, preventive measures for metabolic bone disease, and colon-cancer screening.

The study population consisted of 21 with ulcerative colitis, 44 with Crohn's disease and 2 in whom the diagnosis of IBD could not be confirmed.

Of the 65 patients with confirmed IBD, the researchers noted that 56 patients had symptoms of active disease and 9 were asymptomatic.

All analyses were carried out on the 56 patients with active disease.

Of the 33 patients treated with aminosalicylates, the researchers reported that 21 were not receiving maximal doses.

The research team found that 9 of 12 patients with distal ulcerative colitis were not receiving rectal aminosalicylate therapy.

Within 6 months of their clinic visit, 35 patients had received corticosteroid therapy.

The team observed that 27 patients had been treated with corticosteroids for greater than 3 months.

The research team found that in 16 of 27 there was no attempt to start steroid sparing medications such as 6-mercaptopurine, azathioprine, or infliximab.

Of the 11 patients treated with either 6-mercaptopurine or azathioprine, 9 were suboptimally dosed without an attempt to increase dosage.

In addition, the team noted that of the 27 patients on prolonged corticosteroid therapy 21 received inadequate treatment to prevent metabolic bone disease.

The researchers also observed that 3 of 9 patients meeting indications for surveillance colonoscopy for dysplasia, had not undergone colonoscopy at the appropriate interval.

Dr Sarathchandra's team concluded, “Patients with IBD often do not receive optimal medical therapy.”

“In particular, there is suboptimal dosing of 5-ASA and immunomodulatory medications, and prolonged use of corticosteroids.”

“There is also failure to use steroid-sparing agents, inadequate measures to prevent metabolic bone disease, and inadequate screening for colorectal cancer.”

Am J Gastroenterol 2005: 100(6): 1357
14 June 2005

Go to top of page Email this page Email this page to a colleague

 18 January 2018 
Sleeve gastrectomy vs Roux-en-Y gastric bypass
 18 January 2018 
Healthcare costs of liver cancer in the USA
 18 January 2018 
High-risk adenomas at colonoscopy
 17 January 2018 
“Weekend effect” in upper GI hemorrhage
 17 January 2018 
Gut dysbiosis and non-antibiotic prescription medications
 17 January 2018 
Reducing surgical infections in high-outlier colorectal unit
 16 January 2018 
Bundle of care in GI cancer surgery
 16 January 2018 
Anxiety about colonoscopy
 16 January 2018 
Thiopurines and colorectal neoplasia in IBD
 15 January 2018 
Risks of death after liver transplants for liver cancer
 15 January 2018 
Recent advances in hepatocellular carcinoma
 15 January 2018 
Ileostomy output using telemedicine
 12 January 2018 
Surveillance protocols after colorectal cancer resection
 12 January 2018 
Biologic therapy by pregnant women with IBD and infant vaccines
 12 January 2018 
Biologic therapies for IBD in the USA
 11 January 2018 
Genetic risk factors in GERD
 11 January 2018 
Predictor of colorectal adenoma
 11 January 2018 
Ectopic pregnancy in IBD 
 10 January 2018 
Fecal immunochemical tests for colorectal cancer screening
 10 January 2018 
Risk factors for advanced NAFLD
 10 January 2018 
Dyspepsia prevalence with gastroesophageal reflux–type symptoms
 09 January 2018 
Screening intervals for people with family histories of colorectal cancer
 09 January 2018 
Financial impact of colorectal cancer
 09 January 2018 
Current practice and future research in autoimmune hepatitis
 08 January 2018 
Improving prognosis in patients with primary sclerosing cholangitis
 08 January 2018 
Reliability of the IBD index
 08 January 2018 
Aprepitant and nausea with gastroparesis
 05 January 2018 
Autoimmune pancreatitis and IBD
 05 January 2018 
Primary nonresponse to infliximab therapy
 05 January 2018 
Anesthesia assistance in outpatient colonoscopy
 04 January 2018 
Dietary polyphenols in the etiology of IBD
 04 January 2018 
Yoga vs low-FODMAP in IBS
 04 January 2018 
Local esophageal food allergen injections in eosinophilic esophagitis
 03 January 2018 
Population health management for IBD
 03 January 2018 
GERD in asthma and COPD
 03 January 2018 
Critical research gaps in colorectal cancer
 22 December 2017 
Costs of extrahepatic manifestations of Hep C
 22 December 2017 
Cholera vaccine and risk of death in colorectal cancer
 22 December 2017 
Colonoscopy after colorectal cancer resection
 21 December 2017 
Human oral microbiome and pancreatic cancer risk
 21 December 2017 
Health management for IBD
 21 December 2017 
PPI and Alzheimer's disease
 20 December 2017 
Management of abnormal liver blood tests
 20 December 2017 
Incidence of biopsy-verified celiac disease
 20 December 2017 
Osteoporotic fractures in Barrett's esophagus
 19 December 2017 
Alcohol abstinence and alcoholic hepatitis
 19 December 2017 
Family burden of pediatric Crohn's in the USA
 19 December 2017 
Early readmission in IBD patients
 18 December 2017 
Colorectal cancer mortality with low-risk adenomas at colonoscopy
 18 December 2017 
Disease activity indices in celiac disease
 18 December 2017 
Smoking behaviour predicted the risk of surgery in Crohn's
 15 December 2017 
Molecular classification of Crohn's disease
 15 December 2017 
Medical cannabinoid legalization policy and vomiting
 15 December 2017 
Inflammatory diet pattern and colorectal cancer risk
 14 December 2017 
PPIs and gastric cancer after H.pylori eradication
 14 December 2017 
H. pylori eradication therapies in countries with clarithromycin resistance
 13 December 2017 
Disease severity in NAFLD
 13 December 2017 
Tryptophan metabolism and IBD activity
 12 December 2017 
Risk factors in undiagnosed cirrhosis
 12 December 2017 
Monitored anesthesia care for outpatient GI endoscopy

Blackwell Publishing


GastroHep.com is a Blackwell Publishing registered trademark
© 2018 Wiley-Blackwell and GastroHep.com and contributors
Privacy Statement
Disclaimer
About Us